![Arnold Vroege](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Arnold Vroege
No más puestos en curso
Historial de carrera de Arnold Vroege
Antiguos cargos conocidos de Arnold Vroege.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
![]() Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Corporate Officer/Principal | 23/06/2010 | 11/03/2013 |
Stichting Volksgezondheid en Milieu | Corporate Officer/Principal | 01/01/2000 | - |
Solvay Pharmaceuticals SA
![]() Solvay Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals SA develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolics, influenza vaccines, adjuvants, and women's and men's healthcare products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids and dyslipidemia products that control cholesterol and triglycerides. The firm is headquartered in Brussels, France. | Corporate Officer/Principal | 01/01/2003 | - |
Formación de Arnold Vroege.
University of Groningen | Undergraduate Degree |
Estadísticas
Internacional
Países Bajos | 4 |
Bélgica | 2 |
Operativa
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Sectorial
Consumer Services | 2 |
Commercial Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Amsterdam Molecular Therapeutics (AMT) Holding NV
![]() Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands. | Commercial Services |
Solvay Pharmaceuticals SA
![]() Solvay Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Solvay Pharmaceuticals SA develops, manufactures, and supplies pharmaceutical products. The company's products include cardio-metabolics, influenza vaccines, adjuvants, and women's and men's healthcare products. It offers fenofibrate, a cardio-metabolic product for treating raised blood lipids and dyslipidemia products that control cholesterol and triglycerides. The firm is headquartered in Brussels, France. | Health Technology |
Stichting Volksgezondheid en Milieu | Miscellaneous |
- Bolsa de valores
- Insiders
- Arnold Vroege
- Experiencia